DHR Health Patient Recovers From COVID-19 After Receiving Convalescent Plasma Transfusion

Translate to Spanish or other 102 languages!

Matias Rios is discharged from the Serious Infectious Disease Unit (SIDU) at DHR Health after battling a life-threatening SARS-CoV-2 infection.

Mega Doctor News

- Advertisement -

Edinburg, TX  For over a month, DHR Health patient, Matias Rios, 51, battled a life-threatening COVID-19 infection while admitted in the Serious Infectious Disease Unit (SIDU). Upon arrival at DHR Health, he presented with bilateral pneumonia and tested positive for SARS-CoV-2. After being placed on a ventilator for two weeks with minimal improvement, consent was obtained from his authorized guardian, allowing Mr. Rios to receive a transfusion of Convalescent Plasma.  

DHR Health Institute for Research and Development has created the Rio Grande Valley’s first Convalescent Plasma program to treat patients with severe and life-threatening SARS-CoV-2 infection. Mr. Rios is one of many patients in the Rio Grande Valley whose transfusion was facilitated by this program.

One day after the transfusion Mr. Rios condition started to improve and he was removed from his ventilator. Mr. Rios is now on the road to full recovery, thanks to the extraordinary team of physicians and nurses who played a vital role in his recovery at the Serious Infectious Disease Unit (SIDU), which is located offsite on DHR Health campus to isolate and treat COVID-19 patients.

- Advertisement -

Convalescent Plasma Program at DHR Health Institute for Research and Development has provided a very important option in the treatment of COVID-19 patients. In total, seventeen (17) patients have successfully received transfusions of convalescent plasma at DHR Health and at four (4) additional partnering hospitals in the region. The demand for plasma remains high as patients in the Rio Grande Valley continue to experience life-threating COVID-19.  In order to fulfill the gradually increasing demand for convalescent plasma, DHR Health Institute for Research and Development is seeking individuals who have recovered from COVID-19 and who are willing to donate blood and/or plasma for the benefit of the community.

Mr. Rios credits his faith, his will to live and his family who motivated and supported him even though they were not able to be by his side. “Esta experiencia nos marca,” says Rios. “Pero tengo un agradecimiento muy grande con el hospital. Tengo recuerdos muy bonitos.” 

“This experience left its mark on me,” says Rios, “But I have a lot of gratitude towards the hospital. I have a lot of beautiful memories [from my time in the hospital].” 

Mr. Rios has been discharged from the SIDU and is currently home, continuing to recover while being cared for by Mrs. Rios  his wife, with whom he has been with for over 35 years. He is now walking without assistance and is completing a set of daily exercises recommended by his physicians. His advice to any other person or family who’s loved one is fighting COVID-19, is “never give up and trust in God.”

- Advertisement -

To learn if you qualify as a donor, please visit https://b.link/DHRHIRD_COVID19, or call (956) 215-3166 / (956) 342-4896. You can also email dhrresearch@dhr-rgv.com to request more information. 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

What Persistent Fatigue Might Be Telling You

Mega Doctor News CLEVELAND CLINIC - We’ve all had those days where we’re...

AMA Unveils New Initiative to Boost Nutrition Education Nationwide

The American Medical Association (AMA) is launching a nutrition education initiative to equip physicians and medical students with practical, evidence-based knowledge and tools to help patients live healthier lives.

Study Finds GLP‑1 Therapy Reduces Heart and Kidney Risks for Type 1 Diabetes Patients

People with type 1 diabetes who took GLP-1 receptor agonist (GLP-1-RA) drugs for weight loss or better blood-sugar control had significantly reduced risks of major cardiovascular events and end-stage kidney disease without any increase in safety concerns, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

The Silent Toll of Substance Use on Today’s Young Adults

Mega Doctor News by University of Michigan Newswise - Young adults who heavily use substances...
- Advertisement -